Menu

Blog

Archive for the ‘biotech/medical’ category: Page 289

May 14, 2023

Food, Mood, and Brain Health: Implications for the Modern Clinician

Posted by in categories: biotech/medical, health, neuroscience

Improved, innovative strategies are needed for the prevention and promotion of recovery from mental illness as these disorders leading cause of disability worldwide. This article will review the evidence linking dietary pattern to brain-based illnesses and provide an overview of the mechanisms that underlie the association between brain health and the food we eat. Considerations for dietary intervention will be discussed including encouraging a shift towards a traditional or whole foods dietary pattern.


Robert, a 43-year-old married man who presents with irritability and a low mood for two months. He has a history of attention deficit disorder, first diagnosed two years ago, and is currently treated with Vyvanse 70 mg. While his focus and work function are improved, he reports low appetite, fatigue, and difficulty sleeping. He notes that he tends to be quite irritable during mealtimes to the extent that his wife has asked him to stay at work past dinnertime to “stay out of the way.” He feels guilty and, concerned about not connecting emotionally to his young children ages 1 and 3. Further history and medical workup reveal no substance use, no active medical issues, and blood work reveals no abnormalities.

The evidence is growing: food choice is strongly implicated in mental health risk. In cases like Robert’s, a food history is a vital piece of data, both in assessing low appetite as a possible medication side effect, or as a symptom of depression. Furthermore, a food history is imperative to understand whether targeted dietary recommendations could assist in his recovery.

Continue reading “Food, Mood, and Brain Health: Implications for the Modern Clinician” »

May 14, 2023

Potential found to counter depression

Posted by in categories: biotech/medical, neuroscience

Led by researchers from NYU Grossman School of Medicine and University of Szeged in Hungary, a new study in mice and rats found that restoring certain signals in a brain region that processes smells countered depression.

Publishing in the journal Neuron online May 9, the study results revolve around nerve cells (neurons), which “fire”—or emit —to transmit information. Researchers in recent years discovered that effective communication between brain regions requires groups of neurons to synchronize their activity patterns in repetitive periods (oscillations) of joint silence followed by joint activity.

One such rhythm, called “gamma,” repeats about 30 times or more in a second, and is an important timing pattern for the encoding of complex information, potentially including emotions.

May 14, 2023

The Pangenome Breakthrough: A Crystal Clear Image of Human Genomic Diversity

Posted by in categories: biotech/medical, evolution, genetics, health

In a major advance, scientists have assembled genomic sequences of 47 people from diverse backgrounds to create a pangenome, which offers a more accurate representation of human genetic diversity than the existing reference genome. This new pangenome will help researchers refine their understanding of the link between genes and diseases, and could ultimately help address health disparities.

For more than 20 years, scientists have relied on the human reference genome, a consensus genetic sequence, as a standard against which to compare other genetic data. Used in countless studies, the reference genome has made it possible to identify genes implicated in specific diseases and trace the evolution of human traits, among other things.

But it has always been a flawed tool. One of its biggest problems is that about 70 percent of its data came from a single man of predominantly African-European background whose DNA.

May 14, 2023

Sundar Pichai says ethicists and philosophers need to be involved in the development of AI to make sure it is moral, and doesn’t do things like lie

Posted by in categories: biotech/medical, ethics, robotics/AI

As generative AI gains traction and companies rush to incorporate it into their operations, concerns have mounted over the ethics of the technology. Deepfake images have circulated online, such as ones showing former President Donald Trump being arrested, and some testers have found that AI chatbots will give advice related to criminal activities, such as tips for how to murder people.

AI is known to sometimes hallucinate — make up information and continuously insist that it’s true — creating fears that it could spread false information. It can also develop bias and in some cases has argued with users. Some scammers have also used AI voice-cloning software in attempts to pose as relatives.

“How do you develop AI systems that are aligned to human values, including morality?,” Pichai said. “This is why I think the development of this needs to include not just engineers, but social scientists, ethicists, philosophers, and so on.”

May 14, 2023

This Company Is Using Enzymatic DNA Synthesis To Usher In The Next Generation Of Synthetic Biology Innovation

Posted by in categories: bioengineering, biotech/medical, chemistry, computing, food

DNA writing is an aspect of our industry that I’ve been closely watching for several years because it is a critical component of so many groundbreaking capabilities, from cell and gene therapies to DNA data storage. At the SynBioBeta Conference in 2018, the co-founder of a new startup that was barely more than an idea gave a lightning talk on enzymatic DNA synthesis — and I was so struck by the technology the company was aiming to develop that I listed them as one of four synthetic biology startups to watch in 2019. I watched them, and I wasn’t disappointed.

Ansa Biotechnologies, Inc. — the Emeryville, California-based DNA synthesis startup using enzymes instead of chemicals to write DNA — announced in March the successful de novo synthesis of a 1005-mer, the world’s longest synthetic oligonucleotide, encoding a key part of the AAV vector used for developing gene therapies. And that’s just the beginning. Co-founder Dan Lin-Arlow will be giving another lightning talk at this year’s SynBioBeta Conference in just a few weeks. I caught up with him in the lead up and was truly impressed by what Ansa Biotechnologies has accomplished in just 5 years.

Synthetic DNA is a key enabling technology for engineering biology. For nearly 40 years, synthetic DNA has been produced using phosphoramidite chemistry, which facilitates the sequential addition of new bases to a DNA chain in a simple cyclic reaction. While this process is incredibly efficient and has supported countless innovative breakthroughs (a visit to Twist Bioscience’s website will quickly educate you on exciting advances in drug discovery, infectious disease research, cancer therapeutics, and even agriculture enabled by synthetic DNA) it suffers from two main drawbacks: its reliance on harsh chemicals and its inability to produce long (read: complex) DNA fragments.

May 14, 2023

It’s Confirmed: Babies With DNA From Three People Are Now Being Born in The UK

Posted by in categories: biotech/medical, genetics, government

Eight years after the technology was approved by government authorities, it can be reported that at least one child with DNA from three different people has been born to parents in the United Kingdom.

The announcement isn’t exactly ‘new’ knowledge, but reporters at The Guardian were able to prompt an official confirmation with a freedom of information request.

The University of Newcastle in collaboration with the Newcastle Fertility Center are pioneers in what is known as mitochondrial replacement therapy (MRT), a special form of in vitro fertilization (IVF) designed to prevent severe genetic diseases in future babies.

May 14, 2023

Scientists identify genes that can repair the retina and reverse vision loss in humans

Posted by in category: biotech/medical

There is an army of dormant cells in our eyes that prefer to stay asleep. However, waking them up in patients living with degenerative retinal disease can prevent blindness.

Researchers at the Université de Montréal (UdeM) have proposed a novel treatment strategy that promises to restore vision in patients living with degenerative retinal disease, an inherited medical condition that gradually impairs a person’s ability to read text, sense colors, see objects that are placed sideways, and eventually makes them completely blind.

Continue reading “Scientists identify genes that can repair the retina and reverse vision loss in humans” »

May 14, 2023

This Longevity Study Across 5 Species Found a New Pathway to Reverse Aging

Posted by in categories: biotech/medical, genetics, life extension

A new study in Nature hunted down another piece to the aging puzzle. In five species across the evolutionary scale—worms, flies, mice, rats, and humans—the team honed in on a critical molecular process that powers every single cell inside the body and degrades with age.

The process, called transcription, is the first step in turning our genetic material into proteins. Here, DNA letters are reworked into a “messenger” called RNA, which then shuttles the information to other parts of the cell to make proteins.

Scientists have long suspected that transcription may go awry with aging, but the new study offers proof that it doesn’t—with a twist. In all five of the species tested, as the organism grew older the process surprisingly sped up. But like trying to type faster when blindfolded, error rates also shot up.

May 14, 2023

Vitamin B6: Did It Increase NAD? (Test Results)

Posted by in categories: biotech/medical, genetics

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Continue reading “Vitamin B6: Did It Increase NAD? (Test Results)” »

May 13, 2023

Resurrecting a 2.6 billion-year-old ancient CRISPR system

Posted by in categories: bioengineering, biotech/medical, employment, food

Incapable of replicating on their own, viruses must hijack other organisms, like bacteria, to continue their existence. Little wonder, then, that bacteria had to develop ways to fight back.

Among them is CRISPR, a kind of an immune system that keeps DNA records of previous infections and then uses a protein called Cas to attack viruses that show up again. When Cas reaches a targeted virus, it cleaves the viral DNA, protecting the bacteria from infection.

Researchers have harnessed that targeted, DNA-snipping ability as a gene editing tool for all kinds of organisms. CRISPR can now be found in a variety of fields doing a variety of jobs, from helping to fight sickle cell and high cholesterol in humans to gene editing animals and crops. It’s proven to be an amazingly versatile tool.

Page 289 of 2,403First286287288289290291292293Last